Published in J Clin Med on October 24, 2014
Pluripotent stem cells in disease modelling and drug discovery. Nat Rev Mol Cell Biol (2016) 1.24
Epithelial-Mesenchymal Transition (EMT): A Biological Process in the Development, Stem Cell Differentiation and Tumorigenesis. J Cell Physiol (2017) 0.78
Functional Divergence of the Nuclear Receptor NR2C1 as a Modulator of Pluripotentiality During Hominid Evolution. Genetics (2016) 0.77
Molecular Characterization of Down Syndrome Embryonic Stem Cells Reveals a Role for RUNX1 in Neural Differentiation. Stem Cell Reports (2016) 0.75
Generation of Cholinergic and Dopaminergic Interneurons from Human Pluripotent Stem Cells as a Relevant Tool for In Vitro Modeling of Neurological Disorders Pathology and Therapy. Stem Cells Int (2016) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Reprogramming of human somatic cells to pluripotency with defined factors. Nature (2007) 30.84
Disease-specific induced pluripotent stem cells. Cell (2008) 16.95
Epigenetic memory in induced pluripotent stem cells. Nature (2010) 14.31
Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science (2008) 14.26
Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature (2008) 12.21
Somatic coding mutations in human induced pluripotent stem cells. Nature (2011) 9.50
A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell (2010) 7.51
BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol (2002) 6.20
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature (2009) 5.37
The promise of induced pluripotent stem cells in research and therapy. Nature (2012) 5.05
The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet (1993) 4.57
A guide to genome engineering with programmable nucleases. Nat Rev Genet (2014) 4.15
Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell (2011) 3.73
Turner's syndrome. N Engl J Med (1996) 3.23
Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell (2010) 3.08
Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell (2007) 2.87
The pathophysiology of fragile x syndrome. Annu Rev Genomics Hum Genet (2007) 2.85
Huntington's disease. Pathogenesis and management. N Engl J Med (1986) 2.77
Autistic behavior in children with fragile X syndrome: prevalence, stability, and the impact of FMRP. Am J Med Genet A (2006) 2.61
Autism spectrum disorder in fragile X syndrome: communication, social interaction, and specific behaviors. Am J Med Genet A (2004) 2.58
Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell (2012) 2.55
Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Annu Rev Pathol (2011) 2.39
Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. J Biol Chem (2010) 2.10
Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells. Stem Cells (2004) 2.07
Overcoming reprogramming resistance of Fanconi anemia cells. Blood (2012) 2.07
Turner's syndrome. Lancet (2001) 1.94
Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage. Blood (2010) 1.88
Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum Mol Genet (2011) 1.87
Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature (2014) 1.81
Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell (2013) 1.80
Human embryonic stem cell lines with genetic disorders. Reprod Biomed Online (2005) 1.80
Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS One (2011) 1.75
Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells. PLoS Curr (2010) 1.70
Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell (2014) 1.65
Normal phenotype in two brothers with a full FMR1 mutation. Hum Mol Genet (1995) 1.63
Human embryonic stem cells: research, ethics and policy. Hum Reprod (2003) 1.50
Concise review: Induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart? Stem Cells (2012) 1.50
Differentiation of trophoblast cells from human embryonic stem cells: to be or not to be? Reproduction (2014) 1.49
Molecular dissection of the events leading to inactivation of the FMR1 gene. Hum Mol Genet (2004) 1.46
Reprogrammed cells for disease modeling and regenerative medicine. Annu Rev Med (2013) 1.45
Opportunities and challenges of pluripotent stem cell neurodegenerative disease models. Nat Neurosci (2013) 1.38
The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity. Neurobiol Dis (2012) 1.35
Molecular biology of Fanconi anemia: implications for diagnosis and therapy. Blood (1997) 1.35
Concise review: Embryonic stem cells versus induced pluripotent stem cells: the game is on. Stem Cells (2012) 1.28
Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome. EMBO J (2013) 1.24
New perspectives on the biology of fragile X syndrome. Curr Opin Genet Dev (2012) 1.23
Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs. Nat Commun (2014) 1.21
Huntington's and myotonic dystrophy hESCs: down-regulated trinucleotide repeat instability and mismatch repair machinery expression upon differentiation. Hum Mol Genet (2010) 1.21
The behavioral phenotype of FMR1 mutations. Am J Med Genet C Semin Med Genet (2010) 1.12
Pluripotent stem cell models of Shwachman-Diamond syndrome reveal a common mechanism for pancreatic and hematopoietic dysfunction. Cell Stem Cell (2013) 1.10
Laser-assisted derivation of human embryonic stem cell lines from IVF embryos after preimplantation genetic diagnosis. Hum Reprod (2007) 1.06
Brief report: human pluripotent stem cell models of fanconi anemia deficiency reveal an important role for fanconi anemia proteins in cellular reprogramming and survival of hematopoietic progenitors. Stem Cells (2013) 1.03
Derivation of Huntington's disease-affected human embryonic stem cell lines. Stem Cells Dev (2010) 1.03
Studying early lethality of 45,XO (Turner's syndrome) embryos using human embryonic stem cells. PLoS One (2009) 1.02
Modeling abnormal early development with induced pluripotent stem cells from aneuploid syndromes. Hum Mol Genet (2011) 1.00
Neural differentiation of Fragile X human Embryonic Stem Cells reveals abnormal patterns of development despite successful neurogenesis. Dev Biol (2012) 1.00
Recapitulation of spinal motor neuron-specific disease phenotypes in a human cell model of spinal muscular atrophy. Cell Res (2012) 0.97
Human embryonic stem cell research: ethical and legal issues. Nat Rev Genet (2001) 0.97
Genome-wide analysis validates aberrant methylation in fragile X syndrome is specific to the FMR1 locus. BMC Med Genet (2013) 0.97
Human pluripotent stem cells for disease modelling and drug screening. Bioessays (2011) 0.97
Heads-up: new roles for the fragile X mental retardation protein in neural stem and progenitor cells. Genesis (2011) 0.96
Molecular analysis of FMR1 reactivation in fragile-X induced pluripotent stem cells and their neuronal derivatives. J Mol Cell Biol (2012) 0.96
A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration. FASEB J (2013) 0.96
Length-dependent CTG·CAG triplet-repeat expansion in myotonic dystrophy patient-derived induced pluripotent stem cells. Hum Mol Genet (2013) 0.93
Use of rodents as models of human diseases. J Pharm Bioallied Sci (2014) 0.87
Derivation, culture, and characterization of VUB hESC lines. In Vitro Cell Dev Biol Anim (2010) 0.86